10 20 30 40 50 60 70 80 1LSO - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 17-MAY-02 1LSO
TITLE CRYSTAL STRUCTURE OF THE S137A MUTANT OF L-3-HYDROXYACYL- TITLE 2 COA DEHYDROGENASE IN COMPLEX WITH NAD
COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: L-3-HYDROXYACYL-COA DEHYDROGENASE, SHORT CHAIN 3- COMPND 5 HYDROXYACYL-COA DEHYDROGENASE, HCDH; COMPND 6 EC: 1.1.1.35; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A
KEYWDS ROSSMANN FOLD, OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.J.BARYCKI,L.J.BANASZAK
REVDAT 2 24-FEB-09 1LSO 1 VERSN REVDAT 1 03-FEB-04 1LSO 0
JRNL AUTH J.J.BARYCKI,L.J.BANASZAK JRNL TITL CRYSTAL STRUCTURE OF THE S137A MUTANT OF JRNL TITL 2 L-3-HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX WITH JRNL TITL 3 NAD JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BARYCKI,L.K.O'BRIEN,J.M.BRATT,R.ZHANG, REMARK 1 AUTH 2 R.SANISHVILI,A.W.STRAUSS,L.J.BANASZAK REMARK 1 TITL BIOCHEMICAL CHARACTERIZATION AND CRYSTAL STRUCTURE REMARK 1 TITL 2 DETERMINATION OF HUMAN HEART SHORT CHAIN REMARK 1 TITL 3 L-3-HYDROXYACYL-COA DEHYDROGENASE PROVIDE INSIGHTS REMARK 1 TITL 4 INTO CATALYTIC MECHANISM REMARK 1 REF BIOCHEMISTRY V. 38 5786 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9829027
REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 23042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1116 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3603 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 175 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4484 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.89 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.930 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.520 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.440 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 38.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NAD_MOD.PARAM REMARK 3 PARAMETER FILE 4 : CAA_IDEAL_50.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAD.TOP REMARK 3 TOPOLOGY FILE 4 : CAA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1LSO COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-02. REMARK 100 THE RCSB ID CODE IS RCSB016245.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUL-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200HB REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR D*TREK (MSC/ REMARK 200 RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR D*TREK (MSC/ REMARK 200 RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23099 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.830 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.85 REMARK 200 R MERGE FOR SHELL (I) : 0.27200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3HAD REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM N-[2-ACETAMIDO]-2- REMARK 280 IMINODIACETIC ACID WITHIN THE PRECIPITANT RANGE OF 14% TO 19% REMARK 280 POLYETHYLENE GLYCOL 4000, PH 6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.18050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.84350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.22600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.84350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.18050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.22600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICALLY RELEVANT DIMER CONTAINED WITHIN THE REMARK 300 ASYMMETRIC UNIT
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 67 16.48 -64.46 REMARK 500 LYS A 68 -4.10 -145.11 REMARK 500 PHE A 70 45.99 -140.25 REMARK 500 ALA A 107 59.63 -150.36 REMARK 500 ILE A 108 -167.32 -107.76 REMARK 500 VAL A 109 141.32 -37.51 REMARK 500 ALA A 127 172.97 -56.37 REMARK 500 PHE A 205 -113.28 51.18 REMARK 500 ARG A 224 4.34 -66.28 REMARK 500 ASP A 269 85.83 -164.59 REMARK 500 PRO A 277 172.38 -54.45 REMARK 500 GLU A 287 10.49 -64.51 REMARK 500 ASN A 288 -9.17 67.74 REMARK 500 LYS A 289 90.64 -64.05 REMARK 500 GLU A 296 137.37 -173.42 REMARK 500 LYS B 16 -40.40 -138.32 REMARK 500 PHE B 70 37.34 -99.42 REMARK 500 VAL B 109 127.96 -39.52 REMARK 500 LYS B 113 -78.68 -63.35 REMARK 500 VAL B 114 -33.96 -36.94 REMARK 500 ASN B 146 23.12 -61.70 REMARK 500 PRO B 203 139.30 -38.49 REMARK 500 PHE B 205 -117.17 53.02 REMARK 500 ILE B 206 -78.29 -106.19 REMARK 500 ASP B 269 48.23 -168.88 REMARK 500 ALA B 270 -3.71 -46.77 REMARK 500 PRO B 279 -71.83 -50.68 REMARK 500 LYS B 289 77.33 -102.23 REMARK 500 LYS B 293 46.69 -80.67 REMARK 500 THR B 294 -17.13 -172.00 REMARK 500 TYR B 301 -165.04 -123.01 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HAD RELATED DB: PDB REMARK 900 1HAD IS THE WILD-TYPE L-HYDROXYACYL-COA DEHYDROGENASE IN REMARK 900 COMPLEX WITH NAD REMARK 900 RELATED ID: 1LSJ RELATED DB: PDB REMARK 900 1LSJ IS THE CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3- REMARK 900 HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX WITH NAD
DBREF 1LSO A 1 302 UNP Q16836 HCDH_HUMAN 7 308 DBREF 1LSO B 1 302 UNP Q16836 HCDH_HUMAN 7 308
SEQADV 1LSO ALA A 137 UNP Q16836 SER 143 ENGINEERED SEQADV 1LSO ALA B 137 UNP Q16836 SER 143 ENGINEERED
SEQRES 1 A 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 A 302 ILE PHE ALA SER ASN THR ALA SER LEU GLN ILE THR SER SEQRES 12 A 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 302 LYS TYR LYS SEQRES 1 B 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 302 VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 B 302 ILE PHE ALA SER ASN THR ALA SER LEU GLN ILE THR SER SEQRES 12 B 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 302 LYS TYR LYS
HET NAD A 350 44 HET NAD B 750 44
HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE
FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 5 HOH *73(H2 O)
HELIX 1 1 GLY A 24 THR A 37 1 14 HELIX 2 2 THR A 47 LYS A 67 1 21 HELIX 3 3 ASN A 73 THR A 87 1 15 HELIX 4 4 ASP A 93 THR A 101 5 9 HELIX 5 5 ASN A 111 ALA A 126 1 16 HELIX 6 6 GLN A 140 ASN A 146 1 7 HELIX 7 7 ARG A 150 ASP A 152 5 3 HELIX 8 8 SER A 178 LEU A 192 1 15 HELIX 9 9 ILE A 206 ARG A 224 1 19 HELIX 10 10 SER A 228 GLY A 241 1 14 HELIX 11 11 GLY A 245 GLY A 254 1 10 HELIX 12 12 GLY A 254 ASP A 269 1 16 HELIX 13 13 SER A 278 GLU A 287 1 10 HELIX 14 14 GLY B 24 THR B 37 1 14 HELIX 15 15 THR B 47 PHE B 70 1 24 HELIX 16 16 ASN B 73 THR B 87 1 15 HELIX 17 17 ASP B 93 VAL B 98 1 6 HELIX 18 18 HIS B 99 THR B 101 5 3 HELIX 19 19 ASN B 111 ALA B 126 1 16 HELIX 20 20 GLN B 140 ASN B 146 1 7 HELIX 21 21 ARG B 150 ASP B 152 5 3 HELIX 22 22 SER B 178 LEU B 192 1 15 HELIX 23 23 ILE B 206 ARG B 224 1 19 HELIX 24 24 SER B 228 GLY B 241 1 14 HELIX 25 25 GLY B 245 GLY B 254 1 10 HELIX 26 26 GLY B 254 MET B 268 1 15 HELIX 27 27 ASN B 272 GLN B 276 5 5 HELIX 28 28 SER B 278 GLU B 287 1 10
SHEET 1 A 8 ILE A 88 SER A 91 0 SHEET 2 A 8 THR A 40 VAL A 44 1 N VAL A 41 O ALA A 89 SHEET 3 A 8 HIS A 17 ILE A 21 1 N VAL A 20 O VAL A 42 SHEET 4 A 8 LEU A 103 GLU A 106 1 O LEU A 103 N THR A 19 SHEET 5 A 8 ILE A 131 SER A 134 1 O ALA A 133 N GLU A 106 SHEET 6 A 8 PHE A 154 HIS A 158 1 O ALA A 155 N PHE A 132 SHEET 7 A 8 LEU A 168 LYS A 173 -1 O ILE A 172 N GLY A 156 SHEET 8 A 8 HIS A 195 LYS A 200 1 O VAL A 197 N VAL A 171 SHEET 1 B 8 ILE B 88 SER B 91 0 SHEET 2 B 8 THR B 40 VAL B 44 1 N VAL B 41 O ALA B 89 SHEET 3 B 8 HIS B 17 ILE B 21 1 N VAL B 18 O THR B 40 SHEET 4 B 8 LEU B 103 GLU B 106 1 O LEU B 103 N THR B 19 SHEET 5 B 8 ILE B 131 SER B 134 1 O ALA B 133 N GLU B 106 SHEET 6 B 8 PHE B 154 PHE B 159 1 O LEU B 157 N SER B 134 SHEET 7 B 8 LEU B 168 LYS B 173 -1 O GLU B 170 N HIS B 158 SHEET 8 B 8 HIS B 195 LYS B 200 1 O VAL B 197 N VAL B 171
CISPEP 1 ASN A 161 PRO A 162 0 -0.31 CISPEP 2 ASN B 161 PRO B 162 0 -0.50
SITE 1 AC1 17 GLY A 24 LEU A 25 MET A 26 ASP A 45 SITE 2 AC1 17 GLN A 46 ALA A 107 ILE A 108 VAL A 109 SITE 3 AC1 17 GLU A 110 LYS A 115 ASN A 135 ALA A 137 SITE 4 AC1 17 HIS A 158 HOH A 801 HOH A 825 HOH A 834 SITE 5 AC1 17 HOH A 855 SITE 1 AC2 16 GLY B 24 LEU B 25 MET B 26 ASP B 45 SITE 2 AC2 16 GLN B 46 ILE B 108 VAL B 109 GLU B 110 SITE 3 AC2 16 VAL B 114 LYS B 115 ASN B 135 ALA B 137 SITE 4 AC2 16 HIS B 158 PHE B 159 HOH B 820 HOH B 854
CRYST1 50.361 86.452 167.687 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019857 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011567 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005963 0.00000